Matinas BioPharma Holdings, Inc. (MTNB)
 NYSEAMERICAN: MTNB · Real-Time Price · USD
 1.360
 +0.020 (1.49%)
  At close: Oct 30, 2025, 4:00 PM EDT
1.360
 0.00 (0.00%)
  After-hours: Oct 30, 2025, 8:00 PM EDT
MTNB Market Cap
MTNB has a market cap or net worth of $7.55 million as of October 30, 2025. Its market cap has decreased by -52.50% in one year.
Market Cap 
 7.55M
Enterprise Value 
 3.56M
1-Year Change 
 -52.50%
Ranking 
 Category 
 Stock Price 
$1.36
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $7.55M, a decrease of -96.62%. That is a compound annual growth rate of -32.36%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 6.80M | 161.54% | 
| Dec 31, 2024 | 2.60M | -94.47% | 
| Dec 29, 2023 | 47.00M | -56.64% | 
| Dec 30, 2022 | 108.40M | -50.37% | 
| Dec 31, 2021 | 218.40M | -19.41% | 
| Dec 31, 2020 | 271.00M | -26.64% | 
| Dec 31, 2019 | 369.40M | 452.17% | 
| Dec 31, 2018 | 66.90M | -37.94% | 
| Dec 29, 2017 | 107.80M | -51.77% | 
| Mar 2, 2017 | 223.50M | - | 
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 741.90B | 
| Johnson & Johnson | 457.53B | 
| AbbVie | 402.83B | 
| UnitedHealth Group | 331.46B | 
| AstraZeneca | 259.35B | 
| Novartis AG | 250.89B | 
| Novo Nordisk | 235.38B | 
| Abbott Laboratories | 221.35B |